Cargando…

Efficacy and safety of ozonated autohemotherapy in patients with hyperuricemia and gout: A phase I pilot study

Gout is a common form of arthritis; however, there are currently no effective therapies available. Ozonated autohemotherapy (O(3)-AHT) is a controversial, but successful method of treatment for a number of diseases. The present study is the first pilot study investigating the application of O(3)-AHT...

Descripción completa

Detalles Bibliográficos
Autores principales:	LI, LIAN-YUN, NI, JIA-XIANG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186361/ https://www.ncbi.nlm.nih.gov/pubmed/25289033 http://dx.doi.org/10.3892/etm.2014.1951

Ejemplares similares

Ozonated autohemotherapy modulates the serum levels of inflammatory cytokines in gouty patients
por: Li, Lian-Yun, et al.
Publicado: (2017)

The effect and safety of ozone autohemotherapy combined with pharmacological therapy in postherpetic neuralgia
por: Hu, Bin, et al.
Publicado: (2018)

Recovery of Four COVID-19 Patients via Ozonated Autohemotherapy
por: Wu, Junping, et al.
Publicado: (2020)

No effects of ozonated autohemotherapy on inflammation response in hemodialyzed patients.
por: Tylicki, Leszek, et al.
Publicado: (2004)

Effects of ozonated autohemotherapy on the antioxidant capacity of Thoroughbred horses
por: TSUZUKI, Nao, et al.
Publicado: (2015)

Clinical efficacy and metabolomic analysis of ozone major autohemotherapy for the treatment of herpes zoster
por: Yang, Jing, et al.
Publicado: (2023)

Efficacy and safety of lesinurad for the treatment of hyperuricemia in gout
por: Pérez-Ruiz, Fernando, et al.
Publicado: (2019)

A Novel Molecular Approach for Enhancing the Safety of Ozone in Autohemotherapy and Insights into Heme Pocket Autoxidation of Hemoglobin
por: Naderi Beni, Ramin, et al.
Publicado: (2023)

Ozonated autohemotherapy: protection of kidneys from ischemia in rats subjected to unilateral nephrectomy
por: Foglieni, Chiara, et al.
Publicado: (2011)

Magnetic resonance diffusion tensor imaging following major ozonated autohemotherapy for treatment of acute cerebral infarction
por: Wu, Xiao-na, et al.
Publicado: (2016)

Major ozonated autohemotherapy promotes the recovery of upper limb motor function in patients with acute cerebral infarction
por: Wu, Xiaona, et al.
Publicado: (2013)

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
por: Becker, Michael A, et al.
Publicado: (2010)

Gout. Novel therapies for treatment of gout and hyperuricemia
por: Terkeltaub, Robert
Publicado: (2009)

Susceptibility genes of hyperuricemia and gout
por: Nian, Yue-Li, et al.
Publicado: (2022)

The need for a correct oxygen-ozone autohemotherapy (O(3)-AHT) in patients with mild to moderate COVID-19 pneumonia
por: Chirumbolo, Salvatore, et al.
Publicado: (2021)

Rapid and Sustained Effect of Ozone Major Autohemotherapy for Raynaud and Hand Edema in Systemic Sclerosis Patient: A Case Report
por: Galluccio, Felice
Publicado: (2022)

Combining Ozonated Autohemotherapy with Pharmacological Therapy for Comorbid Insomnia and Myofascial Pain Syndrome: A Prospective Randomized Controlled Study
por: Shen, Wang, et al.
Publicado: (2022)

Management of hyperuricemia in gout: focus on febuxostat
por: Reinders, Mattheus K, et al.
Publicado: (2010)

An update on the genetic architecture of hyperuricemia and gout
por: Merriman, Tony R
Publicado: (2015)

Pharmacological effects of Chatuphalatika in hyperuricemia of gout
por: Sato, Vilasinee Hirunpanich, et al.
Publicado: (2018)

The role of the Mediterranean diet in hyperuricemia and gout
por: Stamostergiou, Julie, et al.
Publicado: (2018)

Atypical musculoskeletal manifestations of gout in hyperuricemia patients
por: Sakti, Muhammad, et al.
Publicado: (2019)

Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Greatly Improved Fatigue Symptoms When Treated with Oxygen-Ozone Autohemotherapy
por: Tirelli, Umberto, et al.
Publicado: (2021)

A concise history of gout and hyperuricemia and their treatment
por: Nuki, George, et al.
Publicado: (2006)

Performance of Ultrasound in the Clinical Evaluation of Gout and Hyperuricemia
por: Cao, Ling, et al.
Publicado: (2021)

Why Does Hyperuricemia Not Necessarily Induce Gout?
por: Zhang, Wei-Zheng
Publicado: (2021)

The biomarkers discovery of hyperuricemia and gout: proteomics and metabolomics
por: Wu, Xinghong, et al.
Publicado: (2023)

Efficacy and safety of acupoint autohemotherapy in treating stable chronic obstructive pulmonary disease: Protocol for a systematic review and meta-analysis
por: Hong, Haidu, et al.
Publicado: (2019)

Febuxostat in the management of hyperuricemia and chronic gout: a review
por: Hu, Miao, et al.
Publicado: (2008)

Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout
por: Gaffo, Angelo L, et al.
Publicado: (2010)

Febuxostat: A Novel Agent for Management of Hyperuricemia in Gout
por: Bisht, Manisha, et al.
Publicado: (2011)

Circulating microRNA alternations in primary hyperuricemia and gout
por: Bohatá, Jana, et al.
Publicado: (2021)

Treatment for hyperuricemia and gout in Japan: Aspect of prescription and duration
por: Zhang, Di
Publicado: (2022)

Associations of metal exposure with hyperuricemia and gout in general adults
por: Xu, Jing, et al.
Publicado: (2022)

Epidemiology and treatment-related concerns of gout and hyperuricemia in Korean
por: Ahn, Joong Kyong
Publicado: (2023)

Personalizing the safe, appropriate and effective concentration(s) of ozone for a non-diabetic individual and four type II diabetic patients in autohemotherapy through blood hemoglobin analysis
por: Mehraban, Fouad, et al.
Publicado: (2019)

Autohemotherapy in Chronic Urticaria: What Could Be the Autoreactive Factors and Curative Mechanisms?
por: Sheikhi, Abdolkarim, et al.
Publicado: (2014)

Advances in the management of gout: Critical appraisal of febuxostat in the control of hyperuricemia
por: Beara-Lasic, Lada, et al.
Publicado: (2010)

Gout, not hyperuricemia alone, impairs left ventricular diastolic function
por: Lin, Jing-Chi, et al.
Publicado: (2015)

The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout—An Update
por: Eckenstaler, Robert, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_72pqoqte018liklq6ag0022476